Biomarin Pharmaceutical Inc at Cowen Healthcare Conference (Virtual) Transcript
Good afternoon and welcome once again to Cowen and Company's 41st Annual Healthcare Conference. Hopefully, our only virtual edition. I am Phil Nadeau, a biotech analyst here at Cowen. And it's my pleasure to moderate a fireside chat with BioMarin Pharmaceutical. Those of you who follow our research know that we've been fans of this business model for quite some time. So we're happy to have with us today, J.J. Bienaime, Chairman and CEO; as well as Brian Mueller, Chief Financial Officer.
Questions & Answers
J.J., maybe we'll start with you. Could you give a brief state of the company overview, biggest strengths, biggest challenges? And what has to happen to create shareholder value over the next year or 2?
Thank you, Phil. Thank you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
